The future of biosimilars in the UK: regulation, access and medicines optimisation

When Jun 08, 2017 from 09:00 AM to 01:00 PM
Where London
Add event to calendar vCal

This seminar will provide the opportunity to discuss the future of biosimilar medicines in the UK.

Delegates will assess the next steps for regulation and pharmacovigilance, the impact of increased competition between originator and biosimilar manufacturers and the challenges for embedding use in service delivery following the publication of NHS England’s ‘What is a biosimilar medicine?’ guide.

Sessions will also focus on the implications of the UK vote to leave the European Union on access to biosimilars, key issues for clinicians around switching from originator to biosimilar - and the next steps for patient engagement, education and involvement. 

More information about this event…